People: Research!America Organization Elects Duke Chancellor Emeritus As Chairman

The board of directors of Research!America, a nonprofit organization whose focus is on educating the public about the benefits of biomedical research, has elected William G. Anlyan chairman. Anlyan, who since 1950 has been a Duke University professor of surgery and currently is a chancellor, emeritus, at Duke, assumed the lead position of Research!America's policy- making body on September 8. Anlyan says that, as the new chairman of the Alexandria-Va.-based organization--which has 165 instit

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Anlyan says that, as the new chairman of the Alexandria-Va.-based organization--which has 165 institutional members across the United States--"I see great potential to increase the public's understanding of the importance of biomedical research." Anlyan intends to pay particular attention to broadening the awareness of scientific research among young people in the United States.

The U.S., Anlyan says, is already the clear leader in biomedical research, but he believes the government should be funding more basic studies.

He notes that biomedical research has already led to great progress in medicine. In this regard, he says, "The beginning of September marked the 45th anniversary of the first day I became a third-year medical student at Yale. I put on a short white coat and stethoscope around my neck. At the university hospital, we had a whole wing that was filled with infectious diseases: one floor of tuberculosis, another floor of polio, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ron Kaufman

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo